Emergent Biosolutions
NYSE: EBSGaithersburg, US · Delaware corporation · 2 known investors
Emergent BioSolutions is a public health company that develops, manufactures, and supplies medical countermeasures for national security and preparedness, along with commercialized products addressing threats such as the opioid epidemic. It also provides in-house development and manufacturing support to biopharma innovators, governments, and non-governmental organizations.
Founders & leadership
FE
Fuad El-HibriFounder
RG
Robert G KramerExecutive
KS
Katherine StreiExecutive
AR
Adam R HaveyExecutive
DJ
Daniel J Abdun-NabiExecutive
ZH
Zsolt HarsanyiNamed on SEC filing
Board
GJ
George J. JoulwanBoard director
RB
Ronald B RichardBoard director
SB
Sue BaileyBoard director
LW
Louis W SullivanBoard director
KC
Kathryn C ZoonBoard director
JM
Jerome M HauerBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$47.9M disclosed across 1 round · 2018
▶$47.9MraisedOct 2018 · 8 investors · BiotechnologyRule 506(b)
▶$47.9MraisedOct 2018 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- George J. JoulwanDirector
- Robert G KramerExecutive Officer
- Ronald B RichardDirector
- Katherine StreiExecutive Officer
- Fuad El-HibriDirector, Executive Officer
- Adam R HaveyExecutive Officer
- Sue BaileyDirector
- Daniel J Abdun-NabiExecutive Officer, Director
- Louis W SullivanDirector
- Zsolt HarsanyiDirector
- Kathryn C ZoonDirector
- Jerome M HauerDirector
- Richard S. LindahlExecutive Officer
- Atul SaranExecutive Officer
- Offering amount
- $47.9M
- Amount sold
- $47.9M
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapWalgreens190 shared keywordsWalgreens operates a pharmacy and retail health and wellness business, offering prescription services, over-the-counter medications, health products, and photo services to consumers.
Medscape160 shared keywordsMedscape is an online medical information platform providing clinical news, expert perspectives, case studies, quizzes, and reference material across specialties such as cardiology, oncology, neurology, and psychiatry. It serves physicians, nurses, pharmacists, residents, and medical students.
Companies competing with Emergent Biosolutions for the same Google search keywords, organic and paid, via search-intersection analysis.
Acquisitions · 1
Early investors' stakes continue via these dealsTrubion
Acquired by Emergent BioSolutions
In the news
Frequently asked questions
- What does Emergent Biosolutions do?
- Emergent BioSolutions is a public health company that develops, manufactures, and supplies medical countermeasures for national security and preparedness, along with commercialized products addressing threats such as the opioid epidemic. It also provides in-house development and manufacturing support to biopharma innovators, governments, and non-governmental organizations.
- Who founded Emergent Biosolutions?
- Emergent Biosolutions was founded by Fuad El-Hibri.
- Who are Emergent Biosolutions's investors?
- Emergent Biosolutions's investors include Advent Life Sciences, OrbiMed.
- How much funding has Emergent Biosolutions raised?
- Emergent Biosolutions has disclosed $47.9M raised across 1 round.
- Where is Emergent Biosolutions headquartered?
- Emergent Biosolutions is headquartered in Gaithersburg, US.